Target intelligence / Profile preview

Outer membrane protein PorA (PorA)

Target
PorA
Molecular classification
Porin, Beta-barrel protein, Outer membrane protein, General bacterial porin (gbp) family, Ion channel
01

Overview

Outer membrane protein PorA is a major surface-exposed porin found in Neisseria species, most notably Neisseria meningitidis, where it serves as a critical component of the bacterial outer membrane [1, 3]. Structurally, it forms a trimeric beta-barrel that functions as a cation-selective channel, facilitating the transport of essential nutrients while maintaining membrane integrity [3, 8]. Beyond its physiological role, PorA is a potent immunogen and a primary target for the host's bactericidal immune response [2, 11]. It is a key antigen in several licensed and experimental vaccines, particularly those targeting serogroup B meningococci, such as the outer membrane vesicle (OMV) component of Bexsero [6, 10]. In the context of disease, PorA contributes to the pathogenesis of invasive meningococcal disease, including meningitis and sepsis, by mediating adhesion to host cells and facilitating immune evasion [1, 5]. The protein exhibits significant antigenic diversity, primarily localized within two variable regions (VR1 and VR2), which allows the bacteria to escape recognition by existing antibodies [5, 12]. This high degree of variability and the potential for phase variation present major challenges for the development of universal vaccines, often requiring "tailor-made" or multi-antigen formulations to ensure broad coverage [2, 11]. Therapeutic strategies focus on inducing high titers of serum bactericidal antibodies (SBA) that trigger complement-mediated lysis of the pathogen [6, 7]. Additionally, PorA is used as a primary marker for the serosubtyping of meningococcal strains in epidemiological surveillance [5, 9].

Other names
Class 1 outer membrane proteinP1Porin IAClass 1 OMPMajor outer membrane protein P.IA
02

Mechanism of action

Induction of serum bactericidal antibodies (SBA) leading to complement-mediated bacterial lysis

03

Biological functions

Cation transmembrane transportCell adhesionImmune evasionStructural integrity
04

Disease associations

Meningococcal diseaseMeningitisSepsisInfectionGonorrhea
05

Safety considerations

Antigenic variationPhase variationStrain-specific protectionImmune escape
06

Interacting drugs

Bexsero

2 more in the full profile.

07

Biomarkers

Serum bactericidal antibody (SBA) titerPorA serosubtypePorA genotype

Beyond the preview

Go deeper on Outer membrane protein PorA (PorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein PorA (PorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call